期刊
NATURAL PRODUCT COMMUNICATIONS
卷 17, 期 3, 页码 -出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/1934578X221080929
关键词
pyrroloquinoline quinone; pyrroloquinoline quinone supplementation; mRNA vaccines
The spike protein-induced heart inflammation from COVID-19 infection or mRNA vaccines can possibly be reduced by supplementation with pyrroloquinoline quinone (PQQ), although there is currently no evidence supporting this claim.
SARS-CoV-2 spike protein-induced heart inflammation may originate from either COVID-19 infection or the administration of COVID-19 mRNA vaccines. As pyrroloquinoline quinone (PQQ) is a scavenger of free radicals, redox cofactor, and antioxidant which supports cognitive and mitochondrial functions, supplementation with PQQ could have a positive effect to reduce heart inflammation after COVID-19 mRNA vaccines. However, there is no evidence yet for this opportunity in the literature. Cellular and animal model results are missing. Similarly, no clinical trials have been conducted. While it is recommended to measure the levels of the cardiac biomarkers before and after COVID-19 vaccination, no recommendation can be made about supplementation with PQQ, which, however, we note has no contraindication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据